KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Short term Debt (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 15 years of Short term Debt data on record, last reported at $587.1 million in Q4 2025.

  • For Q4 2025, Short term Debt fell 31.97% year-over-year to $587.1 million; the TTM value through Dec 2025 reached $587.1 million, down 31.97%, while the annual FY2025 figure was $587.1 million, 31.97% down from the prior year.
  • Short term Debt reached $587.1 million in Q4 2025 per ZBH's latest filing, down from $600.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $1.9 billion in Q2 2024 and bottomed at $300.0 million in Q1 2021.
  • Average Short term Debt over 5 years is $873.1 million, with a median of $836.0 million recorded in 2022.
  • Peak YoY movement for Short term Debt: plummeted 84.62% in 2021, then skyrocketed 382.54% in 2024.
  • A 5-year view of Short term Debt shows it stood at $1.6 billion in 2021, then plummeted by 66.09% to $544.3 million in 2022, then surged by 65.35% to $900.0 million in 2023, then fell by 4.11% to $863.0 million in 2024, then plummeted by 31.97% to $587.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $587.1 million in Q4 2025, $600.0 million in Q3 2025, and $820.0 million in Q2 2025.